<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02765009</url>
  </required_header>
  <id_info>
    <org_study_id>2015-A00662-47</org_study_id>
    <nct_id>NCT02765009</nct_id>
  </id_info>
  <brief_title>Effects of Fluid Balance Control in Critically Ill Patients</brief_title>
  <acronym>POINCARE</acronym>
  <official_title>Effects of Fluid Balance Control in Critically Ill Patients: A Multicenter Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Most ICU patients develop a positive fluid balance, mainly during the two first weeks of
      their stay. The causes are multifactorial: a reduced urine output subsequent to shock state,
      positive pressure mechanical ventilation, acute renal failure, post-operative period of major
      surgical procedures, and simultaneous fluid loading to maintain volemia and acceptable
      arterial pressure. Additionally, the efficacy of fluid loading is frequently suboptimal, in
      relation to severe hypoalbuminemia and inflammatory capillary leakage. This results usually
      in a cumulated positive fluid balance of more than 10 litres at the end of the first week of
      stay. A high number of studies have showed that such a positive fluid balance was an
      independent factor of worse prognosis in selected populations of ICU patients: acute renal
      failure, acute respiratory distress syndrome (ARDS), sepsis, post-operative of high risk
      surgery. However, little is known about the putative causal role of positive fluid balance by
      itself on outcome. However, in two randomized controlled studies in patients with ARDS, a
      strategy of fluid balance control has been demonstrated to reduce time under mechanical
      ventilation and ICU length of stay with no noticeable adverse effects. Although avoiding
      fluid overload is now recommended in ARDS management, there is no evidence that this approach
      would be beneficial in a more general population of ICU patients (i.e. with sepsis, acute
      renal failure, mechanical ventilation). In addition, fluid restriction -mainly if applied
      early could be deleterious in reducing both tissue oxygen delivery and perfusion pressure.
      There is a place for a prospective study comparing a &quot;conventional&quot; attitude based on liberal
      fluid management throughout the ICU stay with a restrictive approach aiming at controlling
      fluid balance, at least as soon as the patient circulatory status is stabilized. The latter
      approach would use a simple algorithm using fluid restriction and diuretics based on daily
      weighing, a common procedure in the ICU, probably more reliable than cumulative measurement
      of fluid movements in patients whose limits have been underlined.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 2016</start_date>
  <completion_date type="Anticipated">July 2019</completion_date>
  <primary_completion_date type="Anticipated">July 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality at 60 days after inclusion</measure>
    <time_frame>60 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean differences of weight between Day 7 and Day 0</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean differences of weight between Day 14 and Day 0</measure>
    <time_frame>14 days</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Time-related changes of sequential organ failure assessment (SOFA) score until day 28</measure>
    <time_frame>28 days</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Cumulated number of vasopressor free days from Day 0 to Day 28</measure>
    <time_frame>28 days</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Cumulated number of ventilator free days from Day 0 to Day 28</measure>
    <time_frame>28 days</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Cumulated number of renal replacement free days from Day 0 to Day 60</measure>
    <time_frame>60 days</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Cumulated number of pre-defined adverse events</measure>
    <time_frame>14 days</time_frame>
    <description>Pre-defined adverse events include Systolic arterial pressure&lt; 90 mm Hg, kalemia &lt; 2,8 mmol/L, natremia &gt;155 mmol/L, &quot;injury&quot; level of renal dysfunction (RIFLE scale)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1716</enrollment>
  <condition>Fluid Shifts</condition>
  <condition>Critical Care</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual care provided according to the ward policy. Patients have to be weighed at least on admission (day 0), day 7 and day 14.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Strategy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients have to be weighed every day. Use of an algorithm based on weight changes from day 2 to day 14 in order to reduce weight gain (fluid overload) using diuretics, fluid restriction,albumin, and ultrafiltration (the latter when ongoing renal replacement)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>diuretics</intervention_name>
    <description>Used to reduce fluid overload as evidenced by weight gain</description>
    <arm_group_label>Strategy</arm_group_label>
    <other_name>hydrochlorothiazide</other_name>
    <other_name>bumetanide</other_name>
    <other_name>furosemide</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>albumin</intervention_name>
    <description>Used to reduce fluid overload in addition with diuretics in hypoalbuminemic patients</description>
    <arm_group_label>Strategy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>fluid restriction</intervention_name>
    <description>Used to reduce fluid overload</description>
    <arm_group_label>Strategy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>renal replacement</intervention_name>
    <description>Used to reduce fluid overload in patients with renal replacement</description>
    <arm_group_label>Strategy</arm_group_label>
    <other_name>ultrafiltration</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients under mechanical ventilation, admitted for &gt; 48h and &lt;72h and no discharge
             planned for the next 24h

        Exclusion Criteria:

          -  Age &lt; 18 years

          -  Failure to weigh the patient

          -  Multiple trauma

          -  Transfer from another ICU with a previous stay &gt; 24h

          -  High probability of withdrawing treatment for ethical purposes within 7 days

          -  Pregnancy

          -  Patient refusal
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>El Mehdi Siaghy</last_name>
    <role>Study Director</role>
    <affiliation>Nancy University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pierre-Edouard Bollaert, MD, PhD</last_name>
    <phone>0033(0)383851494</phone>
    <email>pe.bollaert@chru-nancy.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hopital Nord Franche-Comt√©</name>
      <address>
        <city>Belfort</city>
        <zip>90000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Julio Badie, MD</last_name>
      <phone>0033(0)384985667</phone>
      <email>Julio.badie@hnfc.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire</name>
      <address>
        <city>Dijon</city>
        <zip>21000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Pierre Quenot, MD, PhD</last_name>
      <phone>0033(0)380293751</phone>
      <email>jean-pierre.quenot@chu-dijon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire</name>
      <address>
        <city>Lyon</city>
        <zip>69000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Laurent Argaud, MD, PhD</last_name>
      <phone>0033(0)472110015</phone>
      <email>laurent.argaud@chu-lyon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier R√©gional</name>
      <address>
        <city>Metz</city>
        <zip>57000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guillaume Louis, MD</last_name>
      <phone>0033(0)387553569</phone>
      <email>gus_louis@yahoo.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier R√©gional et Universitaire</name>
      <address>
        <city>Nancy</city>
        <zip>54000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre-Edouard Bollaert, MD,PhD</last_name>
      <phone>0033(0)383851494</phone>
      <email>pe.bollaert@chru-nancy.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier R√©gional et Universitaire</name>
      <address>
        <city>Nancy</city>
        <zip>54000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claire Charpentier, MD</last_name>
      <phone>0033(0)383852037</phone>
      <email>c.charpentier@chru-nancy.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier Saint Joseph</name>
      <address>
        <city>Paris</city>
        <zip>75000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>C√©dric Bruel, MD</last_name>
      <phone>0033(0)144123415</phone>
      <email>cbruel@hpsj.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier intercommunal</name>
      <address>
        <city>Poissy</city>
        <zip>78303</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Herv√© Outin, MD</last_name>
      <phone>0033(0)139275202</phone>
      <email>outin@chi-poissy-st-germain.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier R√©gional et Universitaire</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francis Schneider, MD, PhD</last_name>
      <phone>0033(0)388127922</phone>
      <email>francis.schneider@chru-strasbourg.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CentreHospitalier R√©gional et universitaire</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ferhat Meziani, MD, PhD</last_name>
      <phone>0033(0)388116768</phone>
      <email>ferhat.meziani@chru-strasbour.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier R√©gional</name>
      <address>
        <city>Thionville</city>
        <zip>57000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michel Bemer, MD</last_name>
      <phone>0033(0)382558239</phone>
      <email>m.bemer@chr-metz-thionville.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier</name>
      <address>
        <city>Verdun</city>
        <zip>55100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruno Maire, MD</last_name>
      <phone>0033(3)329838485</phone>
      <email>bmaire@ch-verdun.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 29, 2016</study_first_submitted>
  <study_first_submitted_qc>May 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 6, 2016</study_first_posted>
  <last_update_submitted>July 26, 2017</last_update_submitted>
  <last_update_submitted_qc>July 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Fluid overload</keyword>
  <keyword>Multiple organ failure</keyword>
  <keyword>Diuretics</keyword>
  <keyword>Fluid restriction</keyword>
  <keyword>Body weight</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydrochlorothiazide</mesh_term>
    <mesh_term>Diuretics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

